Santoro Antonio, Mancini Elena, London Gerad, Mercadal Lucile, Fessy Hafedh, Perrone Bruno, Cagnoli Leonardo, Grandi Eleonora, Severi Stefano, Cavalcanti Silvio
Unità Operativa Nefrologia Dialisi Ipertensione, Policlinico S. Orsola-Malpighi, Bologna, Italy.
Nephrol Dial Transplant. 2008 Apr;23(4):1415-21. doi: 10.1093/ndt/gfm730. Epub 2007 Dec 8.
Although sudden death is one of the most frequent causes of death in haemodialysis (HD) patients, the problem of cardiac arrhythmias, the major cause of these outcomes, has been little discussed.
In 30 arrhythmia-prone HD patients, we compared the arrhythmogenic effects of two dialysis techniques differing in dialysate potassium (K) content. Each patient underwent Acetate-Free Biofiltration sessions with constant (2.5 mEq/l) K (AFB) and sessions with decreasing intra-HD K (AFBK), according to a crossover single blind design. Holter ECG recording and plasma electrolyte measurements were performed during each dialysis session.
There was a tendency in the whole sample for arrhythmia appearance in AFBK to be reduced as compared to AFB throughout the 24 hr period, although this reduction was not statistically significant. In the subset of patients sensitive to dialysis as far as arrhythmia onset is concerned, AFBK was systematically less arrhythmogenic than AFB (P < 0.01). The highest difference was achieved around the 14th hour after the end of dialysis, when the premature ventricular contractions in AFB were 3.9 times higher than in AFBK (P < 0.05). Potassium kinetics differed between the two procedures. At the first hour of treatment, the plasma K concentration was lower in AFB than in AFBK (3.67 +/- 0.15 mEq/l in AFB vs 4.06 +/- 0.13 mEq/l in AFBK, P = 0.05).
Our study shows a greater arrhythmogenic activity with the use of a constant and relatively low K concentration as compared to decreasing K profiling in dialysis-sensitive arrhythmic patients. Smoother K removal may well engender a kind of protective effect.
尽管猝死是血液透析(HD)患者最常见的死亡原因之一,但作为这些后果主要原因的心律失常问题却很少被讨论。
在30名易发生心律失常的HD患者中,我们比较了两种透析液钾(K)含量不同的透析技术的致心律失常作用。根据交叉单盲设计,每位患者分别接受了钾浓度恒定(2.5 mEq/l)的无醋酸生物滤过治疗(AFB)以及透析过程中钾浓度递减的无醋酸生物滤过治疗(AFBK)。在每次透析过程中进行动态心电图记录和血浆电解质测量。
在整个样本中,尽管24小时内AFBK中心律失常的发生率与AFB相比有降低趋势,但差异无统计学意义。在就心律失常发作而言对透析敏感的患者亚组中,AFBK的致心律失常性系统性地低于AFB(P < 0.01)。在透析结束后约14小时达到最大差异,此时AFB中的室性早搏比AFBK高3.9倍(P < 0.05)。两种方法的钾动力学不同。在治疗的第一小时,AFB中的血浆钾浓度低于AFBK(AFB中为3.67±0.15 mEq/l,AFBK中为4.06±0.13 mEq/l,P = 0.05)。
我们的研究表明,与在透析敏感的心律失常患者中采用递减钾模式相比,使用恒定且相对较低的钾浓度具有更大的致心律失常活性。更平稳的钾清除可能会产生一种保护作用。